 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/13/2026 |
$1.25 |
$1.29 |
$1.20 |
$1.27 |
74.70K | | 01/14/2026 |
$1.30 |
$1.31 |
$1.22 |
$1.31 |
67.60K | | 01/15/2026 |
$1.32 |
$1.34 |
$1.26 |
$1.34 |
67.20K | | 01/16/2026 |
$1.32 |
$1.39 |
$1.31 |
$1.34 |
133.50K | | 01/20/2026 |
$1.30 |
$1.30 |
$1.15 |
$1.18 |
213.70K |
|
|
| AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular ribonucleic acid (RNA) molecules, and Alferon N Injection (Interferon alfa). Its lead product is an investigational drug called Ampligen (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. | |
|
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on January 13, 2026, AIM opened at $1.25, traded as high as $1.29 and as low as $1.20, and closed at $1.27. Trading volume was a total of 74.70K shares. On January 14, 2026, AIM opened at $1.30, traded as high as $1.31 and as low as $1.22, and closed at $1.31. Trading volume was a total of 67.60K shares. On January 15, 2026, AIM opened at $1.32, traded as high as $1.34 and as low as $1.26, and closed at $1.34. Trading volume was a total of 67.20K shares. On January 16, 2026, AIM opened at $1.32, traded as high as $1.39 and as low as $1.31, and closed at $1.34. Trading volume was a total of 133.50K shares. On January 20, 2026, AIM opened at $1.30, traded as high as $1.30 and as low as $1.15, and closed at $1.18. Trading volume was a total of 213.70K shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/22/2016 |
|
| End date: |
01/20/2026 |
|
| Start price/share: |
$0.08 |
|
| End price/share: |
$1.18 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
1,375.00% |
|
| Average Annual Total Return: |
30.87% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$147,475.93 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/13/2026 | $1.27 | | 01/14/2026 | $1.31 | | 01/15/2026 | $1.34 | | 01/16/2026 | $1.34 | | 01/20/2026 | $1.18 |
|
|
Free AIM Email Alerts:
